RNS Number : 9303R
Taylor Wimpey PLC
05 March 2019
 

Taylor Wimpey plc

5 March 2019

 

Taylor Wimpey plc

Notification of transactions by persons discharging managerial responsibilities:

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

1.   Peter Redfern

2.   Chris Carney

3.   James Jordan

4.   Jennie Daly

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1.   Chief Executive

2.   Group Finance Director

3.   Group Legal Director and Company Secretary

4.   Group Operations Director

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Taylor Wimpey plc

b)

 

LEI

 

 

21380089BTRXTD8S3R66

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1 pence each

 

 

 

GB0008782301

 

 

 

 

b)

 

Nature of the transaction

 

 

Conditional nil cost performance share awards made under the 2017 Taylor Wimpey Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

180.85 pence.

The number of Awards were calculated at the above average closing MMQ over three business days prior to the date of these Awards on 5 March 2019

 

1.   947,770

2.   475,532

3.   440,036

4.   442,356

 

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

2,305,694

 

 

Nil

 

e)

 

Date of the transaction

 

 

5 March 2019

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHSSEFMIFUSESD